Brief Report: Phase II Multicenter Study of Temozolomide in Patients with Cisplatin-Resistant Germ Cell Tumors

Publisher： Karger

E-ISSN： 1423-0232|80|3-4|219-222

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.3-4, 2011-07, pp. : 219-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sunitinib in Patients with Cisplatin-Refractory Germ Cell Tumors

By  

Oncology Research and Treatment, Vol. 35, Iss. 7-8, 2012-07 ,pp. : 455-456

Karger

Access to resources Recommend Favorite

Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

Phase II Study of Temozolomide and Concomitant Whole-Brain Radiotherapy in Patients with Brain Metastases from Solid Tumors

By  

Oncology Research and Treatment, Vol. 30, Iss. 7, 2007-06 ,pp. : 361-366

Karger

Access to resources Recommend Favorite

A Phase II Multi-Center Study of Triple Therapy with Paclitaxel, S-1 and Cisplatin in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 80, Iss. 1-2, 2011-06 ,pp. : 76-83

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer

By  

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 192-196

Karger

Access to resources Recommend Favorite